These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18757733)

  • 1. Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease.
    Steele AD; Hutter G; Jackson WS; Heppner FL; Borkowski AW; King OD; Raymond GJ; Aguzzi A; Lindquist S
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13626-31. PubMed ID: 18757733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).
    Mays CE; Armijo E; Morales R; Kramm C; Flores A; Tiwari A; Bian J; Telling GC; Pandita TK; Hunt CR; Soto C
    J Biol Chem; 2019 Sep; 294(37):13619-13628. PubMed ID: 31320473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RML prions act through Mahogunin and Attractin-independent pathways.
    Gunn TM; Carlson GA
    Prion; 2013; 7(4):267-71. PubMed ID: 23787699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.
    Meneghetti E; Gasperini L; Virgilio T; Moda F; Tagliavini F; Benetti F; Legname G
    Mol Neurobiol; 2019 Sep; 56(9):6035-6045. PubMed ID: 30710214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion.
    Biasini E; Medrano AZ; Thellung S; Chiesa R; Harris DA
    J Neurochem; 2008 Mar; 104(5):1293-308. PubMed ID: 18034781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of prion-induced neurodegeneration.
    Saá P; Harris DA; Cervenakova L
    Expert Rev Mol Med; 2016 Apr; 18():e5. PubMed ID: 27055367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuroprotective role for microglia in prion diseases.
    Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
    J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related alterations affect the susceptibility of mice to prion infection.
    Avrahami D; Gabizon R
    Neurobiol Aging; 2011 Nov; 32(11):2006-15. PubMed ID: 20045218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prion protein knockout mouse: a phenotype under challenge.
    Steele AD; Lindquist S; Aguzzi A
    Prion; 2007; 1(2):83-93. PubMed ID: 19164918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic responses to prion disease in rats.
    Herbst A; Ness A; Johnson CJ; McKenzie D; Aiken JM
    BMC Genomics; 2015 Sep; 16(1):682. PubMed ID: 26341492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated clinical course of prion disease in mice compromised in repair of oxidative DNA damage.
    Jalland CM; Benestad SL; Ersdal C; Scheffler K; Suganthan R; Nakabeppu Y; Eide L; Bjørås M; Tranulis MA
    Free Radic Biol Med; 2014 Mar; 68():1-7. PubMed ID: 24296244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion pathogenesis is independent of caspase-12.
    Steele AD; Hetz C; Yi CH; Jackson WS; Borkowski AW; Yuan J; Wollmann RH; Lindquist S
    Prion; 2007; 1(4):243-7. PubMed ID: 19164919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anle138b prevents PrP plaque accumulation in Tg(PrP-A116V) mice but does not mitigate clinical disease.
    Qin K; Zhao L; Solanki A; Busch C; Mastrianni J
    J Gen Virol; 2019 Jun; 100(6):1027-1037. PubMed ID: 31045489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration.
    Chen D; Steele AD; Hutter G; Bruno J; Govindarajan A; Easlon E; Lin SJ; Aguzzi A; Lindquist S; Guarente L
    Exp Gerontol; 2008 Dec; 43(12):1086-93. PubMed ID: 18799131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic subclinical prion disease induced by low-dose inoculum.
    Thackray AM; Klein MA; Aguzzi A; Bujdoso R
    J Virol; 2002 Mar; 76(5):2510-7. PubMed ID: 11836429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases.
    Yuan F; Yang L; Zhang Z; Wu W; Zhou X; Yin X; Zhao D
    J Mol Neurosci; 2013 Sep; 51(1):219-24. PubMed ID: 23715697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.